Humulin R

Humulin R: Short-acting insulin for blood sugar control

Humulin R is a short-acting insulin preparation that is used to control blood sugar levels in patients with diabetes. It is an injection solution containing human genetically engineered insulin.

The country of origin of Humulin R is India, where it is produced by M.J. Pharmaceuticals, and France, where it is produced by Eli Lilly.

Humulin R belongs to the pharmacological group of short-acting insulins. It provides a rapid reduction in blood glucose levels after meals, which helps diabetic patients control their glycemic profile.

This drug is available in several dosage forms, including a 40 IU/mL aqueous injection and a 100 IU/mL aqueous injection. It is provided under various trade names and synonyms, such as Actrapid HM, Biosulin R, Gansulin R, Insulin Humulin R, Insulin Humulin Regular, Human Insulin, Human Insulin suspension, Insuman Rapid GT, Insuran R, Humulin Regular, Humulin Regular.

Like any other insulin, Humulin R should be used under medical supervision and in accordance with individual recommendations and dosage regimen. Patients should strictly follow the instructions for use, especially regarding the timing and dosage of the drug.

It is important to note that this article provides general information about Humulin R only and is not a substitute for consultation with a healthcare professional. Patients should consult their doctor or pharmacist for more detailed information about the drug, its use and possible side effects.